Molecular alterations in the neostriatum of human cocaine addicts
Tóm tắt
Molecular changes in the neostriatum of human subjects who died with a history of cocaine abuse were revealed in discrete cell populations by means of the techniques of in situ hybridization histochemistry and in vitro receptor binding and autoradiography. Cocaine subjects had a history of repeated cocaine use and had cocaine and/or cocaine metabolites on board at the time of death. These subjects were compared to control subjects that had both a negative history and toxicology of cocaine use. Selective alterations in mRNA levels of striatal neuropeptides were detected in cocaine subjects compared to control subjects, especially for the opioid peptides. Marked reductions in the levels of enkephalin mRNA and μ opiate receptor binding were found in the caudate and putamen, concomitant with elevations in levels of dynorphin mRNA and κ opiate receptor binding in the putamen and caudate, respectively. Dopamine uptake site binding was reduced in the caudate and putamen of cocaine subjects. The greater magnitude of changes in the dorsolateral striatum (caudate and putamen) as opposed to the ventromedial striatum (nucleus accumbens) suggests that cocaine abuse preferentially alters the biosynthetic activity of striatal systems associated with sensorimotor functioning. Additionally, an imbalance in the activity of the two major striatal output pathways in cocaine users is implicated because peptide mRNA levels were reduced in enkephalinergic striatopallidal neurons and increased in dynorphinergic striatonigral neurons. Another imbalance, that of reductions of transmitter mRNA and receptor expression associated with euphoria (enkephalin and μ opiate receptors), together with elevations in mRNAs of transmitter systems associated with dysphoria (dynorphin and κ opiate receptors), suggests a model of dysphoria and craving in the human cocaine addict brain. © 1993 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Björklund A., 1984, Handbook of Chemical Neuroanatomy, Vol. 2: Classical Transmitters in the CNS, Part I, 55
Chavkin C., 1982, Dynorphin is a specific endogenous ligand for the β‐opioid receptor, Science, 215, 413, 10.1126/science.6120570
Colliver J., 1987, A Decade of Dawn: Cocaine‐Related Cases
Dahlström A., 1964, Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand., 62, 1
DeArmond S. J., 1974, Structure of the Human Brain: A Photographic Atlas, 166
Extein L., 1987, Persistent neurochemical deficit in cocaine abuse, Am. Psychiatr. Assoc. New Res., 61, 52
Fischman N. W., 1984, The behavioral pharmacology of cocaine in humans, NIDA Res. Monogr., 50, 72
Kalivas P. W., 1988, Behavioral and neurochemical effects of acute and daily cocaine administration in rats, J. Pharmacol. Exp. Therap., 245, 485
Parent A., 1986, Comparative Neuroanatomy of the Basal Ganglia
Sivam S. P., 1989, Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism, Pharmacol. Exper. Ther., 250, 818
Xia Y., 1992, Dopamine transporter mRNA content in rat substantia nigra: Cocaine‐related decrease, Soc. Neurosci. Abstr., 18, 474